Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Chorionic villus sampling

  • Shim, Soon-Sup (Department of Obstetrics and Gynecology, Jeju National University School of Medicine)
  • Received : 2014.06.04
  • Accepted : 2014.11.19
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Chorionic villus sampling has gained importance as a tool for early cytogenetic diagnosis with a shift toward first trimester screening. First trimester screening using nuchal translucency and biomarkers is effective for screening. Chorionic villus sampling generally is performed at 10-12 weeks by either the transcervical or transabdominal approach. There are two methods of analysis; the direct method and the culture method. While the direct method may prevent maternal cell contamination, the culture method may be more representative of the true fetal karyotype. There is a concern for mosaicism which occurs in approximately 1% of cases, and mosaic results require genetic counseling and follow-up amniocentesis or fetal blood sampling. In terms of complications, procedure-related pregnancy loss rates may be the same as those for amniocentesis when undertaken in experienced centers. When the procedure is performed after 9 weeks gestation, the risk of limb reduction is not greater than the risk in the general population. At present, chorionic villus sampling is the gold standard method for early fetal karyotyping; however, we anticipate that improvements in noninvasive prenatal testing methods, such as cell free fetal DNA testing, will reduce the need for invasive procedures in the near future.

Keywords

References

  1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110:1459-67. https://doi.org/10.1097/01.AOG.0000291570.63450.44
  2. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27. https://doi.org/10.1097/00006250-200701000-00054
  3. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 27: Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol 2001;97:suppl 1-12. https://doi.org/10.1016/S0029-7844(00)01076-0
  4. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11. https://doi.org/10.1056/NEJMoa043693
  5. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-4. https://doi.org/10.1097/01.AOG.0000423819.85283.f4
  6. Norwitz ER, Levy B. Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol 2013;6:48-62.
  7. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 7th ed. Washington: American College of Obstetricians and Gynecologists, 2012.
  8. Brambati B, Guercilena S, Bonacchi I, Oldrini A, Lanzani A, Piceni L. Feto-maternal transfusion after chorionic villus sampling: clinical implications. Hum Reprod 1986;1:37-40. https://doi.org/10.1093/humrep/1.suppl_2.37
  9. ACOG Technology Assessment No. 11: Genetics and molecular diagnostic testing. Obstet Gynecol 2014;123:394-413. https://doi.org/10.1097/01.AOG.0000443280.91145.4f
  10. South ST, Chen Z, Brothman AR. Genomic medicine in prenatal diagnosis. Clin Obstet Gynecol 2008;51:62-73. https://doi.org/10.1097/GRF.0b013e3181616509
  11. Gardner RJM, Sutherland GR. Chromosome abnormalities and genetic counseling. 3rd ed. New York: Oxford University Press, 2004.
  12. Hsu LY, Benn PA. Revised guidelines for the diagnosis of mosaicism in amniocytes. Prenat Diagn 1999;19:1081-2. https://doi.org/10.1002/(SICI)1097-0223(199911)19:11<1081::AID-PD682>3.0.CO;2-Z
  13. Kalousek DK. Pathogenesis of chromosomal mosaicism and its effect on early human development. Am J Med Genet 2000;91:39-45. https://doi.org/10.1002/(SICI)1096-8628(20000306)91:1<39::AID-AJMG7>3.0.CO;2-L
  14. Evans MI, Wapner RJ. Invasive prenatal diagnostic procedures 2005. Semin Perinatol 2005;29:215-8. https://doi.org/10.1053/j.semperi.2005.06.004
  15. Verp MS. Prenatal diagnosis of genetic disorders. In: Gleicher N, ed. Principles and practice of medical therapy in pregnancy. 2nd ed. Norwalk, CT: Appleton and Lange, 1992:159-70.
  16. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687-94. https://doi.org/10.1097/01.AOG.0000278820.54029.e3
  17. Blumenfeld YJ, Chueh J. Chorionic villus sampling: technique and training. Curr Opin Obstet Gynecol 2010;22:146-51. https://doi.org/10.1097/GCO.0b013e3283372365
  18. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol 2012;40:128-34. https://doi.org/10.1002/uog.10152
  19. Lopez M, Coll O. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther 2010;28:1-8. https://doi.org/10.1159/000309155
  20. Burton BK, Schulz CJ, Burd LI. Spectrum of limb disruption defects associated with chorionic villus sampling. Pediatrics 1993;91:989-93.
  21. Firth HV, Boyd PA, Chamberlain P, MacKenzie IZ, Lindenbaum RH, Huson SM. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 1991;337:762-3. https://doi.org/10.1016/0140-6736(91)91374-4
  22. Centers for Disease Control and Prevention. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR Recomm Rep 1995;44:1-12.
  23. Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014;123:1303-10. https://doi.org/10.1097/AOG.0000000000000275